OptiBiotix Health (GB:OPTI) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
OptiBiotix Health PLC reports positive outcomes from a new study on SlimBiome®, its functional ingredient aimed at reducing hunger and aiding weight loss. The study showed a significant reduction in hunger and increase in fullness among participants, aligning with consumer feedback that suggests decreased snacking and an average weight loss of 1.2kg per week. Amidst these promising results, OptiBiotix emphasizes its ongoing strategic and commercial progress, indicating a confident outlook for continued sales growth into 2025.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.